Articles On Respiri (ASX:RSH)

SaaS health company Respiri was cap in hand in front of investors on Wednesday morning, as it gears up to launch its flagship asthma management product.

At time of writing, the Respiri Ltd [ASX:RSH] share price is up 4.55%, trading at 23 cents. The Melbourne-based biotech company recently announced a manufacturing partner for their new product, wheezo™... The post Respiri Share Price Jumps...

The Respiri Limited (ASX: RSH) share price is up 6.82% to 23.5 cents in early afternoon trading. The surge in the Respiri share price comes following the company’s announcement this morning of a binding electronic manufacturing services (E...

Health technology company Respiri (ASX: RSH) has engaged Entech Electronics to manufacture its “ground breaking” wheezo device offshore in China, which is expected to “significantly improve” production costs. South Australia-based electroni...

The share price of medical technology company Respiri Ltd [ASX:RSH] has pushed higher today thanks to positive results from its latest clinical study. At the time of writing, RSH shares had pushed 3.23% higher to trade at 1.6 cents... The p...

Preliminary results of a clinical study involving the wheezo asthma management platform made by eHealth technology developer Respiri (ASX: RSH) has shown the device is capable of accurately detecting the presence or absence of wheeze in pat...

Special Report: Respiri remains on track to commercialise its wheezo asthma detection device before the end of the year. eHealth company Respiri (ASX:RSH) has continued its run of positive news flow, with the release of new clinical trial d...

Special Report: Respiri ‘kicks a ton’ with new Carlton Football Club AFLW team partnership. Ehealth business Respiri (ASX:RSH) has taken its biggest mark yet for 2021, signing on with the Carlton Football Club’s AFLW team for the upcoming...

A day after publishing its full year accounts, eHealth company Respiri (ASX: RSH) has tentatively set foot in Australian rules football courtesy of a partnership with Carlton Football Club AFLW, commencing from next season. More specificall...

It’s been a mixed year for Respiri Ltd [ASX:RSH]. With markets gripped by the COVID-19 pandemic, shares in the company took a hit. But that didn’t stop the ongoing development of their respiratory monitoring device: wheezo... The post Respi...

eHealth company Respiri (ASX: RSH) has taken another step towards growing sales of its wheezo device ahead of its October launch, after signing a three-year product referral agreement (PRA) with the Australian Patients Association (APA). Th...

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses skyrocketing healthcare spending and its impact on the medtech sub-sector. P...

eHealth Software-as-a-Service (Saas) company Respiri (ASX: RSH) has updated the market with news it has entered into a partnership with the Australian Patients Association (APA) to support asthma sufferers through its wheezo experiential pr...

eHealth technology developer and maker of the wheezo device, Respiri (ASX: RSH) has published interim revenue guidance for 2021 with total revenues from both device and software subscription estimated to reach $6-$8 million. Wheezo is a mod...

Special Report: Respiratory health company Respiri has signed on to Zip Money, a move it expects to boost revenue by 10 per cent. Respiratory health company Respiri (ASX:RSH) has signed on with Zip Co (ASX:Z1P) and says the deal should add...

Respiri (RSH) has signed a merchant services agreement with buy now, pay later giant Zip Co's (Z1P) subsidiary, Zip Money Payments; As more ...

Wheezo developer Respiri’s (ASX: RSH) commercialisation path will accelerate even further after the company collared a deal with renowned buy now pay later provider Zip Co Ltd (ASX: Z1P). Respiri chief executive officer Marjan Mikel said th...

The Respiri Ltd (ASX: RSH) share price has today reached 52-weeks highs, following news that the eHealth company signed a merchant services agreement with major payments share Zip Co Ltd (ASX: Z1P). The Respiri share price is currently tra...

For those with existing respiratory illnesses, like asthma, it has been an even more challenging time. COVID-19 being a far more deadly threat. Which is precisely why companies like Respiri Ltd [ASX:RSH] and their technology are so importan...

A quick wrap of the ASX’s key winners and losers on Friday, July 17. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 712 stocks rose, 606 declined and 789...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Special Report: Respiri’s biggest ever sales agreement will yield significant sales in the first 12 months. Respiri (ASX:RSH), a company whose respiratory monitoring device has been making waves since the COVID-19 pandemic began, has signed...

Healthcare technology developer Respiri (ASX: RSH) has signed an exclusive agreement with global respiratory pharmaceutical firm Cipla for the sales and distribution of Respiri’s wheezo asthma product to its target markets. The five-year ag...

Medical technology is a broad field covering areas like biotechnology, pharmaceuticals, and information technology. Advancements in medical technology improve the way doctors diagnose and treat patients, leading to better health outcomes....

Special Report: The agreement will see data from Respiri’s propriety wheezo technology collated to improve outcomes for asthma research. For electronic health company Respiri (ASX:RSH), the focus is now on expanding the global distribution...

eHealth software company Respiri (ASX: RSH) has unveiled a new partnership agreement with the University of Edinburgh to feed data from its proprietary Wheezo devices into a new data research centre in the UK to advance research into respir...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Clinical t...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Clinical t...

Special Report: Respiratory ehealth business Respiri (ASX:RSH) has signed a deal to educate Australia’s pharmacists on how to further help patients with asthma — and get its wheezo app out there in the process. Respiri has signed a definiti...

Respiri (ASX: RSH) has collared a two-year definitive service agreement with the Pharmacy Guild of Australia to develop an online pharmacist course on optimising asthma patient management including the role of devices such as Respiri’s whee...

Participating in small cap raises is proving lucrative for investors, with shares in 47 small caps that tapped equity markets in April currently trading higher than the price at which they raised cash. Stockhead counted at least 66 offers i...

Respiri (ASX: RSH) has topped up its cash reserves with $3.14 million after receiving “significant oversubscriptions” in a recent share purchase plan. The company launched the share purchase plan last month, with the original offer to raise...

Special Report: eHealth SaaS company Respiri has raised $3.14m in a heavily oversubscribed capital raising, taking its total funds raised to $5.2m   Respiri (ASX:RSH) has closed an oversubscribed share purchase plan, raising $3.14m after he...

As we approach the middle of 2020, the investment environment surrounding the fallout from the COVID-19 pandemic remains complex. Along with threats, there will be plenty of opportunities. And it’s against that backdrop that this week marke...

VidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions and presentations on the most interesting and relevant investment sectors from leading analysts, listed small caps and industry participant...

It’s still a relatively difficult market to raise capital in, particularly at the junior end, but there are some that have convinced investors to part with their hard earned cash. We run through just which small and micro caps successfully...

Special Report: The deal with telehealth platform Practice Innovators International will give Respiri more exposure to a fast-growing sector. Software as a Service (SaaS) health tech company Respiri (ASX:RSH) has scored a key distribution d...

Respiratory health management company Respiri (ASX: RSH) has entered into commercial discussions with Australian start-up Practice Innovators International Pte Ltd with a view to launching an integrated telehealth service for asthma patient...

Shares in Respiri Limited (ASX:RSH), an eHealth SaaS company supporting respiratory health management, hit a high of 11.5 cents on Tuesday, representing a 55% rise relative to its previous closing price of 7.4 cents. The sharp uptick in the...

Respiri (ASX: RSH) has expanded the market for its wheezo technology after announcing a partnership with Phenix Health. The parties have inked a joint development agreement which will involve integrating Respiri’s wheezo eHealth software as...

Australian biotech Genetic Signatures’ (ASX:GSS) is now able to start selling its recently developed COVID-19 diagnostic kit, after it was approved for sale in Australia. The EasyScreen SARS-CoV-2 Detection Kit has been approved to be liste...

Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry. Populatin...

Despite March being a tough month to raise capital for ASX small caps, the money was still flowing for the gold explorers. In March, ASX small caps raised $72.2m, a steep decline from the $125m raised in February. Even in January, tradition...

The COVID-19 pandemic is making capital harder to come by for businesses across the board. But listed health-tech platform Respiri (ASX:RSH) still managed to close the deal, announcing the completion of its $2m share placement yesterday. Am...

The coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves. But as with any major correction, some industries feel the brunt of the impact while for others, the dramatic shift presents an opportunity....

Respiratory focused SaaS company Respiri Limited (ASX: RSH) has experienced inbound demand for its world class wheezo technology from three Chinese hospitals relating to monitoring patients with coronavirus COVID19. According to Respiri, wh...

Jatenergy (ASX:JAT) shares are surging after the company said it booked record sales and revenue in February, as Chinese buyers sucked up its milk products. Revenue was $8.3m for the month. The board has lifted full year guidance from $36m...

Investment bank Lazard believes shareholder activism is going to become more rife in future. Shareholder activism occurs when existing shareholders publically attempt to influence a company’s behaviour. To meet the criteria they have to be...

Healthcare technology developer Respiri (ASX: RSH) has revealed that the company has received the highly coveted CE Mark and TGA approval to list its Wheezo product on the Australian Therapeutics Goods Register (ARTG). Respiri is marketing...

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...